SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-079781
Filing Date
2014-11-12
Accepted
2014-11-12 16:18:13
Documents
4
Period of Report
2014-11-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-24278_18k.htm 8-K 70986
2 EX-10.1 a14-24278_1ex10d1.htm EX-10.1 2089326
3 EX-99.1 a14-24278_1ex99d1.htm EX-99.1 36336
4 GRAPHIC g242781mmi001.jpg GRAPHIC 2542
  Complete submission text file 0001104659-14-079781.txt   2201726
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 141214261
SIC: 2834 Pharmaceutical Preparations